Home
/
BIO KEY INTERNATIONAL INC
/
Financials
/
Quarterly
BIO KEY INTERNATIONAL INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BIO KEY INTERNATIONAL INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$942.4K
Nov 14, 2017
Q2
2017
Jun 30, 2017
$886.9K
Aug 14, 2017
Q1
2017
Mar 31, 2017
$1.42M
May 15, 2017
Q3
2017
Sep 30, 2016
$431.5K
Nov 14, 2017
Q2
2017
Jun 30, 2016
$415.8K
Aug 14, 2017
Q1
2017
Mar 31, 2016
$430.6K
May 15, 2017
Q3
2016
Sep 30, 2015
$669.8K
Nov 14, 2016
Q2
2016
Jun 30, 2015
$2.27M
Aug 15, 2016
Q1
2016
Mar 31, 2015
$648.8K
May 16, 2016
Q3
2015
Sep 30, 2014
$1.28M
Nov 16, 2015
Q2
2015
Jun 30, 2014
$402.8K
Aug 14, 2015
Q1
2015
Mar 31, 2014
$1.37M
May 14, 2015
Q3
2014
Sep 30, 2013
$431.6K
Nov 14, 2014
Q2
2014
Jun 30, 2013
$422.3K
Aug 14, 2014
Q1
2014
Mar 31, 2013
$804.6K
May 12, 2014
Q2
2013
Dec 31, 2012
$1.94M
Aug 14, 2013
Q3
2013
Sep 30, 2012
$409.9K
Nov 14, 2013
Q2
2013
Jun 30, 2012
$532.7K
Aug 14, 2013
Q1
2013
Mar 31, 2012
$1.41M
May 15, 2013
Q3
2012
Sep 30, 2011
$574.1K
Nov 19, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($964.8K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.17M)
Aug 13, 2025
Q3
2025
Jun 30, 2025
($1.17M)
Nov 14, 2025
Q3
2025
Mar 31, 2025
($736.5K)
Nov 14, 2025
Q1
2025
Mar 31, 2025
($736.5K)
May 15, 2025
Q2
2025
Mar 31, 2025
($736.5K)
Aug 13, 2025
Q3
2025
Sep 30, 2024
($739.0K)
Nov 14, 2025
Q3
2025
Jun 30, 2024
($1.67M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($1.67M)
Aug 13, 2025
Q2
2025
Mar 31, 2024
($510.3K)
Aug 13, 2025
Q3
2025
Mar 31, 2024
($510.3K)
Nov 14, 2025
Q1
2025
Mar 31, 2024
($510.3K)
May 15, 2025
Q3
2024
Sep 30, 2023
($1.84M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($2.62M)
Aug 14, 2024
Q3
2024
Jun 30, 2023
($2.62M)
Nov 14, 2024
Q3
2024
Mar 31, 2023
($1.69M)
Nov 14, 2024
Q1
2024
Mar 31, 2023
($1.69M)
Jun 14, 2024
Q2
2024
Mar 31, 2023
($1.69M)
Aug 14, 2024
Q3
2023
Sep 30, 2022
($2.40M)
Nov 20, 2023
Q2
2023
Jun 30, 2022
($1.72M)
Aug 18, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($892.2K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.08M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($640.6K)
May 15, 2025
Q3
2025
Sep 30, 2024
($580.4K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($1.65M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($508.9K)
May 15, 2025
Q3
2024
Sep 30, 2023
($1.97M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($2.38M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($1.76M)
Jun 14, 2024
Q3
2023
Sep 30, 2022
($2.36M)
Nov 20, 2023
Q2
2023
Jun 30, 2022
($1.57M)
Aug 18, 2023
Q1
2023
Mar 31, 2022
($999.5K)
Jun 9, 2023
Q3
2022
Sep 30, 2021
($994.0K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($1.11M)
Aug 17, 2022
Q1
2022
Mar 31, 2021
($836.0K)
May 23, 2022
Q3
2021
Sep 30, 2020
($1.09M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($200.9K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($2.05M)
May 17, 2021
Q3
2020
Sep 30, 2019
($558.4K)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($114.8K)
Aug 14, 2020